Arcadia Biosciences, Inc. — Director's Dealing 2017

Jun 16, 2017

SEC Form 4/A — Form 4/A

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2017-06-07

Reporting Person: Gosbee George Frederick John (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.73	2027-06-07	Common Stock (140816)	140816	Direct

Footnotes

F1: 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.

F2: This filing is to correct the number of options granted on June 7, 2017 to 140,816. All other information remain the same.